نتائج البحث - Martin Jädersten

تنقيح النتائج
  1. 1
    Myelodysplastic syndromes: biology and treatment

    Myelodysplastic syndromes: biology and treatment حسب Martin Jädersten, Eva Hellström‐Lindberg

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival

    Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival حسب Alexandra Löfstedt, Martin Jädersten, Marie Meeths, Jan‐Inge Henter

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF

    Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF حسب Martin Jädersten, Scott Montgomery, Ingunn Dybedal, Anna Porwit‐MacDonald, Eva Hellström-Lindberg

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression

    Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression حسب Martin Jädersten, Leonie Saft, Andrea Pellagatti, Gudrun Göhring, J. S. Wainscoat, Jacqueline Boultwood, Anna Porwit, Brigitte Schlegelberger, Eva Hellström‐Lindberg

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome

    Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome حسب Mattias Carlsten, Bettina C. Baumann, Moa Simonsson, Martin Jädersten, AM Forsblom, Christina Hammarstedt, Yenan T. Bryceson, HG Ljunggren, Eva Hellström‐Lindberg, Karl‐Johan Malmberg

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Erythropoietin and Granulocyte-Colony Stimulating Factor Treatment Associated With Improved Survival in Myelodysplastic Syndrome

    Erythropoietin and Granulocyte-Colony Stimulating Factor Treatment Associated With Improved Survival in Myelodysplastic Syndrome حسب Martin Jädersten, Luca Malcovati, Ingunn Dybedal, Matteo Giovanni Della Porta, Rosangela Invernizzi, Scott Montgomery, Cristiana Pascutto, Anna Porwit, Mario Cazzola, Eva Hellström‐Lindberg

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting

    The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting حسب Gunnar Juliusson, Martin Jädersten, Stefan Deneberg, Sören Lehmann, Lars Möllgård, Lovisa Wennström, Petar Antunović, Jörg Cammenga, Fryderyk Lorenz, Emma Ölander, Vladimir Lazarević, Martin Höglund

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    <i>TP53</i> Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

    <i>TP53</i> Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression حسب Martin Jädersten, Leonie Saft, Alexander Smith, Austin Kulasekararaj, Sabine Pomplun, Gudrun Göhring, Anette Hedlund, Robert Hast, Brigitte Schlegelberger, Anna Porwit, Eva Hellström‐Lindberg, Ghulam J. Mufti

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Haploinsufficiency of <i>RPS14</i> in 5q− syndrome is associated with deregulation of ribosomal‐ and translation‐related genes

    Haploinsufficiency of <i>RPS14</i> in 5q− syndrome is associated with deregulation of ribosomal‐ and translation‐related genes حسب Andrea Pellagatti, Eva Hellström‐Lindberg, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo Giovanni Della Porta, Martin Jädersten, Sally Killick, Carrie Fidler, Mario Cazzola, James S. Wainscoat, Jacqueline Boultwood

    منشور في 2008
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Lenalidomide inhibits the malignant clone and up-regulates the<i>SPARC</i>gene mapping to the commonly deleted region in 5q− syndrome patients

    Lenalidomide inhibits the malignant clone and up-regulates the<i>SPARC</i>gene mapping to the commonly deleted region in 5q− syndrome patients حسب Andrea Pellagatti, Martin Jädersten, Ann‐Mari Forsblom, Helen Cattan, Birger Christensson, Emma K. Emanuelsson, Mats Merup, Lars Nilsson, Jan Samuelsson, Birgitta Sander, James S. Wainscoat, Jacqueline Boultwood, Eva Hellström‐Lindberg

    منشور في 2007
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

    Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period حسب Gunnar Juliusson, Oskar Hagberg, Vladimir Lazarević, Emma Ölander, Petar Antunović, Jörg Cammenga, Lovisa Wennström, Lars Möllgård, Mats Brune, Martin Jädersten, Stefan Deneberg, Sören Lehmann, Åsa Rangert Derolf, Martin Höglund

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Gene expression profiling of CD34<sup>+</sup> cells in patients with the 5q− syndrome

    Gene expression profiling of CD34<sup>+</sup> cells in patients with the 5q− syndrome حسب Jacqueline Boultwood, Andrea Pellagatti, Helen Cattan, Charles H. Lawrie, Aristoteles Giagounidis, Luca Malcovati, Matteo Giovanni Della Porta, Martin Jädersten, Sally Killick, Carrie Fidler, Mario Cazzola, Eva Hellström‐Lindberg, James S. Wainscoat

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Maintenance therapy with the <i>FMS</i>‐like tyrosine kinase 3 inhibitor gilteritinib in patients with <i>FMS</i>‐like tyrosine kinase 3–internal tandem duplication acute myeloid leukemia: A phase 2 study

    Maintenance therapy with the <i>FMS</i>‐like tyrosine kinase 3 inhibitor gilteritinib in patients with <i>FMS</i>‐like tyrosine kinase 3–internal tandem duplication acute myeloid l... حسب Emmanuel Gyan, Mark D. Minden, Kohmei Kubo, Alessandro Rambaldi, Gunnar Juliusson, Martin Jädersten, Richard Kelly, László Szerafin, Wensheng He, Stanley C. Gill, Jason E. Hill, Caroline Chen, David Delgado‐Gómez, Nahla Hasabou

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts

    The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts حسب Jacqueline Boultwood, Andrea Pellagatti, Maryam Nikpour, Beena Pushkaran, Carrie Fidler, Helen Cattan, Tim Littlewood, Luca Malcovati, Matteo Giovanni Della Porta, Martin Jädersten, Sally Killick, Aristoteles Giagounidis, David Bowen, Eva Hellström‐Lindberg, Mario Cazzola, James S. Wainscoat

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

    Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications حسب Christer Nilsson, Fredrika Linde, Erik Hulegårdh, Hege Garelius, Vladimir Lazarević, Petar Antunović, Jörg Cammenga, Stefan Deneberg, Anna Eriksson, Martin Jädersten, Cecilia Kämpe Björkvall, Lars Möllgård, Lovisa Wennström, Emma Ölander, Martin Höglund, Gunnar Juliusson, Sören Lehmann

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations

    Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations حسب Christian Scharenberg, Valentina Giai, Andrea Pellagatti, Leonie Saft, Marios Dimitriou, Monika Jansson, Martin Jädersten, Alf Grandien, Iyadh Douagi, Donna Neuberg, Katarina LeBlanc, Jacqueline Boultwood, Mohsen Karimi, Sten Eirik W. Jacobsen, Petter Woll, Eva Hellström‐Lindberg

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Identification of Gene Expression–Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes

    Identification of Gene Expression–Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes حسب Andrea Pellagatti, Axel Benner, Ken Mills, Mario Cazzola, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo Giovanni Della Porta, Martin Jädersten, Amit Verma, Emma-Jane McDonald, Sally Killick, Eva Hellström‐Lindberg, Lars Bullinger, James S. Wainscoat, Jacqueline Boultwood

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes

    Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes حسب Moritz Gerstung, Andrea Pellagatti, Luca Malcovati, Aristoteles Giagounidis, Matteo Giovanni Della Porta, Martin Jädersten, Hamid Dolatshad, Amit Verma, Nicholas C.P. Cross, Paresh Vyas, Sally Killick, Eva Hellström‐Lindberg, Mario Cazzola, Elli Papaemmanuil, Peter J. Campbell, Jacqueline Boultwood

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities

    Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities حسب Lars Möllgård, Leonie Saft, Marianne Bach Treppendahl, Ingunn Dybedal, Jan Maxwell Nørgaard, Jan Astermark, Elisabeth Ejerblad, Hege Garelius, Inge Høgh Dufva, Monika Jansson, Martin Jädersten, Lars Kjeldsen, Olle Linder, L. Nilsson, Hanne Vestergaard, Anna Porwit, Kirsten Grønbæk, Eva Hellström Lindberg

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

    SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts حسب Luca Malcovati, Mohsen Karimi, Elli Papaemmanuil, Ilaria Ambaglio, Martin Jädersten, Monika Jansson, Chiara Elena, Anna Gallì, Gunilla Walldin, Matteo Giovanni Della Porta, Klas Raaschou‐Jensen, Erica Travaglino, Klaus Kallenbach, Daniela Pietra, Viktor Ljungström, Simona Conte, Emanuela Boveri, Rosangela Invernizzi, Richard Rosenquist, Peter J. Campbell, Mario Cazzola, Eva Hellström Lindberg

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: